Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by the combination of Coriolus versicolor and Ganoderma lucidum

International Journal of Molecular Medicine

Volumn 32, Issue 1, 2013, Pages 251-257

  Hsieh, Tze Chen ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; Cell cycle control; Coriolus versicolor; Ganoderma lucidum

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; GANODERMA LUCIDUM EXTRACT; IM YUNITY TOO; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROTEIN BAX; RETINOBLASTOMA PROTEIN; TRAMETES VERSICOLOR EXTRACT; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CELL CYCLE CHECKPOINT; CELL CYCLE REGULATION; CELL DEATH; CHEMOPROPHYLAXIS; DOWN REGULATION; GANODERMA LUCIDUM; HUMAN; HUMAN CELL; LEUKEMIA CELL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRAMETES VERSICOLOR;

AGARICALES; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; HL-60 CELLS; HUMANS; NF-KAPPA B; REISHI;

EID: 84878241215     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1378     Document Type: Article

References (51)

1. Doll R and Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191-1308, 1981. (Pubitemid 11063920)
2. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2: 325-357, 1991.
3. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96: 1027-1039, 1996. (Pubitemid 27382158)
4. Willett WC: Diet, nutrition, and avoidable cancer. Environ Health Perspect 103 (Suppl 8): 165-170, 1995.
5. Link LB and Potter JD: Raw versus cooked vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 13: 1422-1435, 2004. (Pubitemid 39202308)
6. Potter JD: Vegetables, fruit, and cancer. Lancet 366: 527-530, 2005.
7. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
8. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP and Gescher AJ: Dietary polyphenolic phytochemicals - promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120: 451-458, 2007. (Pubitemid 44969013)
9. de Kok TM, van Breda SG and Manson MM: Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47 (Suppl 2): 51-59, 2008.
10. Link A, Balaguer F and Goel A: Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80: 1771-1792, 2010.
11. Lee KW, Bode AM and Dong Z: Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11: 211-218, 2011.
12. Sliva D: Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2: 358-364, 2003.
13. Yuen JW and Gohel MD: Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53: 11-17, 2005. (Pubitemid 43068549)
14. Paterson RR: Ganoderma - a therapeutic fungal biofactory. Phytochemistry 67: 1985-2001, 2006.
15. Zhou X, Lin J, Yin Y, Zhao J, Sun X and Tang K: Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med 35: 559-574, 2007. (Pubitemid 47307695)
16. Zhong JJ and Xiao JH: Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv Biochem Eng Biotechnol 113: 79-150, 2009.
17. Zhang J, Tang Q, Zhou C, et al: GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci 87: 628-637, 2010.
18. Wasser SP and Weis AL: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19: 65-96, 1999. (Pubitemid 29062102)
19. Cui J and Chisti Y: Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv 21: 109-122, 2003. (Pubitemid 36380288)
20. Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5: 4-27, 2000.
21. Ho CY, Kim CF, Leung KN, et al: Coriolus versicolor (Yunzhi) extract attenuates growth of human leukemia xenografts and induces apoptosis through the mitochondrial pathway. Oncol Rep 16: 609-616, 2006.
22. Nicandro JP, Tsourounis C, Frassetto L and Guglielmo BJ: In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother 7: 39-56, 2007. (Pubitemid 47023570)
23. Hui KP, Sit WH and Wan JM: Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle-dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells. Oncol Rep 14: 145-155, 2005.
24. Hsieh TC, Kunicki J, Darzynkiewicz Z and Wu JM: Effects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta, -6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. J Altern Complement Med 8: 591-602, 2002. (Pubitemid 35291594)
25. Zeng F, Hon CC, Sit WH, et al: Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray. Int J Oncol 27: 513-523, 2005.
26. Hsieh TC, Wu P, Park S and Wu JM: Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP). BMC Complement Altern Med 6: 30, 2006.
27. Hsieh TC and Wu JM: Differential control of growth, cell cycle progression, and gene expression in human estrogen receptor positive MCF-7 breast cancer cells by extracts derived from polysaccharopeptide I'm-Yunity and Danshen and their combination. Int J Oncol 29: 1215-1222, 2006.
28. Hu H, Ahn NS, Yang X, Lee YS and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250-253, 2002. (Pubitemid 35222292)
29. Tsang KW, Lam CL, Yan C, et al: Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med 97: 618-624, 2003. (Pubitemid 36675662)
30. Wong CK, Bao YX, Wong EL, Leung PC, Fung KP and Lam CW: Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med 33: 381-395, 2005. (Pubitemid 40909136)
31. Wan JM, Sit WH and Louie JC: Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. Int J Oncol 32: 689-699, 2008. (Pubitemid 351330476)
32. Luk SU, Lee TK, Liu J, et al: Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One 6: e19804, 2011.
33. Jiang J, Slivova V, Harvey K, Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49: 209-216, 2004. (Pubitemid 39487881)
34. Yue GG, Fung KP, Tse GM, Leung PC and Lau CB: Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med 12: 777-789, 2006. (Pubitemid 44934092)
35. Jiang J, Grieb B, Thyagarajan A and Sliva D: Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med 21: 577-584, 2008.
36. Weng CJ, Chau CF, Yen GC, Liao JW, Chen DH and Chen KD: Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J Agric Food Chem 57: 5049-5057, 2009.
37. Thyagarajan A, Jedinak A, Nguyen H, et al: Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer 62: 630-640, 2010.
38. Hsieh TC and Wu JM: Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3. Int J Mol Med 28: 1065-1069, 2011.
39. Wu G, Qian Z, Guo J, et al: Ganoderma lucidum extract induces G1 cell cycle arrest, and apoptosis in human breast cancer cells. Am J Chin Med 40: 631-642, 2012.
40. Bao PP, Lu W, Cui Y, et al: Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study. PLoS One 7: e39343, 2012.
41. DiPietrantonio AM, Hsieh TC, Olson SC and Wu JM: Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR). Int J Cancer 78: 53-61, 1998. (Pubitemid 28391674)
42. DiPietrantonio AM, Hsieh TC, Juan G, Traganos F, Darzynkiewicz Z and Wu JM: Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation. Cancer Res 60: 4331-4335, 2000. (Pubitemid 32103605)
43. Elangovan S and Hsieh TC: Control of cellular redox status and upregulation of quinone reductase NQO1 via Nrf2 activation by α-lipoic acid in human leukemia HL-60 cells. Int J Oncol 33: 833-838, 2008.
44. Bedner E, Burfeind P, Hsieh TC, et al: Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis pathogen measured by flow and laser scanning cytometry. Cytometry 33: 47-55, 1998. (Pubitemid 28376585)
45. Smolewski P, Bedner E, Du L, et al: Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 44: 73-82, 2001. (Pubitemid 32434005)
46. Hsieh TC, Aguero-Rosenfeld ME, Wu JM, et al: Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE). Biochem Biophys Res Commun 232: 298-303, 1997. (Pubitemid 27216206)
47. Hsieh TC, Yang CJ, Lin CY, Lee YS and Wu JM: Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells. Carcinogenesis 33: 670-677, 2012.
48. Yang CJ, Lin CY, Hsieh TC, Olson SC and Wu JM: Control of eotaxin-1 expression and release by resveratrol and its metabolites in culture human pulmonary artery endothelial cells. Am J Cardiovasc Dis 1: 16-30, 2011.
49. Hsieh TC: Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Asian J Androl 11: 653-661, 2009.
50. Hsieh TC: Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells. Anticancer Res 29: 3011-3017, 2009.
51. Lin CN, Tome WP and Won SJ: Novel cytotoxic principles of Formosan Ganoderma lucidum. J Nat Prod 54: 998-1002, 1991.